G.M. Mead
Impact in
-
- Head and Neck Cancer Studies
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Prostate Cancer Treatment and Research 1
- Surgery 5
- Testicular diseases and treatments 5
- Co-authors
- Sarah Lowndes (1 shared paper)Andrew Lister (1 shared paper)M. Sokal (2 shared papers)S.D. Fosså (3 shared papers)Penny A. Cook (2 shared papers)William G. Jones (1 shared paper)J.T. Roberts (1 shared paper)Gareth Griffiths (1 shared paper)
- Journals
- The Lancet (2 papers)Annals of Oncology (2 papers)European Urology (1 paper)European Journal of Cancer (1 paper)BMJ (1 paper)
- Partner nations
- United Kingdom
In The Last Decade
G.M. Mead
12 papers receiving 180 citations
Peers
Comparison fields: 5 of 43
- Otorhinolaryngology 20
- Genetics 30
- Dermatology 24
- Pathology and Forensic Medicine 45
- Rheumatology 34
Countries citing papers authored by G.M. Mead
This map shows the geographic impact of G.M. Mead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G.M. Mead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G.M. Mead more than expected).
Fields of papers citing papers by G.M. Mead
This network shows the impact of papers produced by G.M. Mead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G.M. Mead. The network helps show where G.M. Mead may publish in the future.
Co-authors
The 25 scholars most cited alongside G.M. Mead, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 79 | |
| 2 | 2002 | 40 | |
| 3 | Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial | 1999 | 16 |
| 4 | 2001 | 13 | |
| 5 | Adjuvant bleomycin, vincristine and cisplatin (BOP) for high risk clinical stage I (HRCS 1) non-seminomatous germ cell tumours (NSGCT) - a Medical Research Council (MRC) pilot study. | 1998 | 12 |
| 6 | 1993 | 6 | |
| 7 | 2002 | 6 | |
| 8 | 18Fluorodeoxyglucose positron emission tomography in the prediction of relapse in patients with high-risk, clinical stage I nonseminomatous germ cell tumors: Preliminary report of MRC trial TE22 - The NCRI testis tumour clinical study group | 2007 | 5 |
| 9 | 1996 | 4 | |
| 10 | Is 3BEP equivalent to 3BEP+1EP in good prognosis germ cell cancer? An EORTC/MRC phase III study | 1999 | 3 |
| 11 | Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06. | 1998 | 1 |
| 12 | 1989 | 1 |
About G.M. Mead
G.M. Mead is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine, Oncology and Dermatology, having authored 12 papers that have together received 186 indexed citations. Recurring topics across this work include Testicular diseases and treatments (5 papers), Lymphoma Diagnosis and Treatment (3 papers), Urologic and reproductive health conditions (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Prostate Cancer Treatment and Research (1 paper), Genetic factors in colorectal cancer (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Otorhinolaryngology (20 citations), Genetics (30 citations), Dermatology (24 citations), Pathology and Forensic Medicine (45 citations) and Rheumatology (34 citations). G.M. Mead has collaborated with scholars based in United Kingdom. Frequent co-authors include Sarah Lowndes, Andrew Lister, M. Sokal, S.D. Fosså, Penny A. Cook, William G. Jones, J.T. Roberts, Gareth Griffiths, Michael Lewis and SP Stenning. Their work appears in journals such as The Lancet, Annals of Oncology, European Urology, European Journal of Cancer and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.